Clinical Trials
27 trialsNCT04183218 2026-05-27
Characterizing Chemo-Radiotherapy Treatment-Related Cardiac Changes
Mayo Clinic
Completed
NCT04572711 2026-05-22
Prospective Evaluation of Biliary Tissue Sampling With ERCP
Mayo Clinic
Completed
NCT06801405 2026-05-19
Antibiotic Prophylaxis in Percutaneous Nephrostomy Placements and Replacements for Malignant Urinary Tract Obstruction
Barretos Cancer Hospital
Completed
NCT05831787 2026-05-18
COSMIC
ASH Research Collaborative
Completed
NCT03516942 2026-05-15
Financial Burden Assessment in Patients With Stage I-III Colon or Rectal Cancer Undergoing Treatment
Eastern Cooperative Oncology Group
Active not recruiting
NCT03983382 2026-05-15
A Study of Limited Heart Monitoring During Non-anthracycline Trastuzumab-based Therapy in Breast Cancer Patients
Memorial Sloan Kettering Cancer Center
Active not recruiting
NCT05599321 2026-05-15
Piloting a Virtual Navigation (VN) System for Bronchoscopic Lung Nodule Sampling
Penn State University
Completed
NCT06790420 2026-05-15
RITUXIMAB BS Intravenous Infusion 100mg・500mg [Pfizer] Post-marketing Database Study
Pfizer
Completed
NCT03933826 2026-05-12
CISTO
University of Washington
Active not recruiting
NCT05076266 2026-05-05
COVID-19 Related Financial Hardship and Distress in Women Who Decline TMIST (EA1151) Participation
Eastern Cooperative Oncology Group
Terminated
NCT04414202 2026-05-01
INTRA-OBS
Institut du Cancer de Montpellier - Val d'Aurelle
Active not recruiting
NCT02165969 2026-04-27
UPSIT
Ohio State University
Terminated
NCT03494660 2026-04-21
SCP Hip Outcomes Study
Zimmer Biomet
Completed
NCT05153187 2026-04-21
Real-world Treatment Patterns of Endocrine Based Therapy Among Patients With Hormone Receptor-positive/Human Epidermal Growth Factor Receptor-2-negative (HR+/HER2-) Advanced Breast Cancer: An Analysis of Administrative Claims Data in Japan
Pfizer
Completed
NCT04107766 2026-04-17
NOLA (NeuWave Observational Liver Ablation) Registry
Ethicon, Inc.
Terminated
NCT04181333 2026-04-14
Safety and Efficacy of Trastuzumab BS
Pfizer
Completed
NCT05105100 2026-04-06
Peripheral T Cell Determinants of Response and Resistance to Pembrolizumab in Melanoma
University of California, San Francisco
Completed
NCT04822350 2026-04-02
AVENANCE
Pfizer
Completed
NCT02348684 2026-04-01
Evaluate Cardiac Function Using Cardiac MRI and Dosimetric Correlation
Medical College of Wisconsin
Completed
NCT03398915 2026-03-31
EUROSPIN
Bergman Clinics
Active not recruiting
NCT05561920 2026-03-31
Phonatory Movement of the Pharyngoesophageal Mucosa in Laryngectomy Patients
Osijek University Hospital
Completed
NCT02362750 2026-03-25
Evaluating Cancer Survivorship Care Models
George Washington University
Completed
NCT05510908 2026-03-25
Use of a Screening Tool to Describe HIV-Related Cancer Burden and Patient Characteristics in the AMC
AIDS Malignancy Consortium
Completed
NCT04877912 2026-03-20
Accurate, Rapid and Inexpensive MRI Protocol for Breast Cancer Screening
University of Chicago
Terminated
NCT04539327 2026-03-18
Analysis of the Clinical Experience With Rucaparib in the Rucaparib Access Program (RAP) in Spain - A GEICO Study
Grupo Español de Investigación en Cáncer de Ovario
Completed
NCT06221397 2026-03-16
LEGIT_MC_EVCDA
AI Labs Group S.L
Completed
NCT06282991 2026-03-10
A Study to Learn About Lorlatinib in Patients With Non-Small Cell Lung Cancer Which Could Not Be Controlled
Pfizer
Completed